Chemiluminescence imaging is a highly sensitive light-based detection technique used in analytical chemistry and molecular biology to detect the presence and quantify analytes like proteins, nucleic acids, small molecules and more. It provides enhanced visualization, quantification and archiving capabilities for bioanalytical assays. The technique delivers high sensitivity with low background noise and produces strong long-lasting signals.
The global Chemiluminescence Imaging Market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growth of the chemiluminescence imaging market is majorly driven by the increasing demand for sensitive detection technologies from the life sciences industry. Chemiluminescence provides detection limits that are approximately 1000 times more sensitive than fluorescence, making it a preferred detection tool for various bioanalytical assays. Chemiluminescent signals can also be easily quantified using cameras and imaging systems, thus providing quantitative data analysis capabilities. Owing to these advantages, chemiluminescence imaging is increasingly being utilized in various applications like protein analysis, nucleic acid detection, immunoassays and more. The high sensitivity and cost-effectiveness of chemiluminescence imaging compared to other techniques is expected to further support the market growth over the forecast period.
SWOT Analysis
Strength: The chemiluminescence imaging market offers several advantages over other imaging techniques such as fluorescence imaging. It does not require external excitation light sources and provides high signal-to-noise ratio.
Weakness: Chemiluminescence reactions are often complex and finding the right reagents that produce sufficient light output can be challenging. Storage and handling of reagents also require proper care.
Opportunity: Expanding applications of chemiluminescence imaging in various end-use industries such as biotechnology & pharmaceutical, academic & research institutes is expected to drive the market growth during the forecast period.
Threats: High costs associated with instruments and reagents may restrain the market growth. Moreover, limitations regarding resolution and multiplexing capabilities as compared to other techniques can hamper the demand.
Key Takeaways
The Global chemiluminescence imaging market Size is expected to witness high growth at a CAGR of 7.5% during the forecast period of 2023-2030.
Regional analysis: North America region currently dominates the chemiluminescence imaging market and is expected to maintain its leading position during the forecast period. This is attributed to the increasing R&D spending and adoption of advanced technologies in the biotechnology and pharmaceutical industries in the US and Canada. Asia Pacific is anticipated to grow at the fastest pace owing to rising healthcare expenditure, growing biomedical industry and increasing research activities in major emerging countries like China and India.
Key players: Key players operating in the chemiluminescence imaging market are Azure Biosystems, Inc., Berthold Technologies GmbH & Co. KG, Carestream Health, Inc., GE Healthcare, LI-COR Biosciences, PerkinElmer, Inc., Syngene International Limited, Tecan Trading AG, Thermo Fisher Scientific Inc., UVItec Limited. They are focusing on new product launches, partnerships, collaborations and geographic expansions to strengthen their market presence.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it